Fischer Medical Ventures Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Low debt relative to equity (D/E 0.1x)
- Near 52-week low — potential value zone (₹22)
Concerns
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,758 | ₹4.2L Cr | 33.2 | 5.05 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,559 | ₹2.4L Cr | 79.8 | 15.15 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,557 | ₹1.7L Cr | 79.3 | 9.43 | 27.4 | 15.2 | 0.77 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,176 | ₹1.1L Cr | 23.1 | 4.37 | 21.2 | 21.1 | 0.38 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,137 | ₹1.1L Cr | 52.8 | 12.35 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,366 | ₹1.1L Cr | 30.2 | 3.21 | 11.6 | 15.5 | 0.01 |
| LAURUSLABS Laurus Labs Limited | ₹2,182 | ₹1.1L Cr | 97.4 | 22.22 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
FISCHER · as of Dec 2025
| Category | Aug 2026 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoters | 61.80% | — | — | 74.91% | 74.91% | 74.91% |
| FII | 5.57% | — | 5.07% | 5.07% | 5.07% | 5.07% |
| DII | 1.42% | — | 1.68% | 1.68% | 1.68% | 1.68% |
| Public | 31.22% | 99.99% | 93.24% | 18.33% | 18.33% | 18.32% |
Latest News
All newsFischer Medical Ventures announces board meeting outcomes.
*Fischer Medical Ventures announces board meeting outcomes.* The company disclosed outcomes from its October 14, 2026 board meeting, including routine corporate matters. No major financial figures or strategic shifts were highlighted. The filing is primarily procedural in nature. 📊 *STOCKS:* $FISCHER | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #BoardMeeting
Fischer Medical Ventures announces board meeting outcomes.
*Fischer Medical Ventures announces board meeting outcomes.* The company disclosed outcomes from its September 24, 2026 board meeting via a stock exchange filing. No **major strategic decisions** or financial announcements were revealed. The update is primarily procedural in nature. 📊 *STOCKS:* $FISCHER | 🏢 *SECTOR:* Pharma | #LOWIMPACT #BoardMeeting
Fischer Medical Ventures announces board meeting outcomes.
*Fischer Medical Ventures announces board meeting outcomes.* The company disclosed outcomes from its recent board meeting held on September 03, 2026. No major strategic shifts or financial announcements were detailed in the filing. The update is primarily procedural in nature. 📊 *STOCKS:* $FISCHER | 🏢 *SECTOR:* Pharma | #LOWIMPACT #BoardMeeting
Fischer Medical wins Philippines healthcare project
*Fischer Medical wins Philippines healthcare project*. Fischer Medical Ventures Limited announced the award of the Catanduanes Integrated Digital Healthcare Project to Time Medical Philippines. The project advances digital universal healthcare in the Philippines and marks a strategic international expansion. Financial details were not disclosed. 📊 *STOCKS:* $FISCHER | 🏢 *SECTOR:* Corporate | #MEDIUMIMPACT #Healthcare
Fischer Medical to install Inter-Op MRI suite via subsidiary
*Fischer Medical to install Inter-Op MRI suite via subsidiary*. Fischer Medical Ventures announced that its wholly owned subsidiary, Time Medical International Ventures (India) Pvt Ltd, has partnered to install an Inter-Op MRI Suite. The collaboration marks a strategic expansion in advanced medical imaging infrastructure. Financial details and partner name were not disclosed. 📊 *STOCKS:* $FISCHER | 🏢 *SECTOR:* Corporate | #MEDIUMIMPACT #healthcare
Fischer Medical publishes FY25-26 annual report for shareholders
*Fischer Medical publishes FY25-26 annual report for shareholders* — Fischer Medical Ventures has published its annual report for FY **2025-26** in a newspaper as part of statutory disclosure requirements. The report is being dispatched to shareholders ahead of the AGM. No financial updates or material events were disclosed. This is a routine compliance filing. 📊 *STOCKS:* $FISCHER | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #AnnualReport
Fischer Medical hosts investor call with no major updates
*Fischer Medical hosts investor call with no major updates*. The company conducted an analyst and institutional investor meet, sharing operational updates without announcing any significant financial or strategic developments. No **revenue**, **profit**, or **guidance** revisions were disclosed. The event was primarily informational in nature. 📊 *STOCKS:* $FISCHER | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #InvestorMeet
Fischer Medical Ventures issues general corporate update
*Fischer Medical Ventures issues general corporate update.* The company filed routine disclosures with the NSE, containing no significant financial or operational changes. Details remain unspecified in the filing. Investors await further clarity on corporate developments. 📊 *STOCKS:* $FISCHER | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #CorporateUpdate
Fischer Medical declares dividend record date
*Fischer Medical declares dividend record date*. Fischer Medical Ventures Limited has set **22-Sep-2026** as the record date for dividend distribution. The announcement confirms the timeline for shareholder eligibility. No dividend amount or percentage was disclosed in this filing. 📊 *STOCKS:* $FISCHER | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Dividend
Fischer Medical publishes notice in newspaper
*Fischer Medical publishes notice in newspaper* as part of regulatory compliance. The filing contains a copy of a newspaper publication, likely for a formal announcement such as a meeting or financial update. No **revenue**, **profit**, or **strategic change** details are disclosed. Impact on trading likely minimal. 📊 *STOCKS:* FISCHER | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #CorporateFiling
About Fischer Medical Ventures Limited
Incorporated in 1993, Fischer Chemic Ltd does trading of chemicals and machineries[1]
HealthcareHealthcare Equipment & Supplies